Syra Health Corp (SYRA)

Every figure this model derived for SYRA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 107 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 2,123,747 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 3,747,154 AssetsCurrent 2026-06-30
current liabilities 1,196,152 LiabilitiesCurrent 2026-06-30
equity 2,633,838 StockholdersEquity 2026-06-30
interest expense 10,862 InterestExpenseNonoperating 2026-06-30
ocf 109,683 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 8,089,943 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 88,926 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up SYRA on one particular measure came for.

RatioValue
cash operating margin2.14
current ratio5.43
current ratio reported3.13
deferred revenue growth89.75
dilution pct57.0
fcf margin1.35
growth cv2.15
interest cover6.88
operating margin0.92
owner earnings margin0.26
revenue growth0.32
revenue growth per share-36.1
roic10.15
rule of 401.24
sbc pct revenue1.1

What to be careful about

What this model itself distrusts about SYRA's figures. Written by the derivation as it ran, not added afterwards.